Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | € 1.53B | € 1.45B | € 1.49B | € 1.87B | € 1.28B |
Total Assets | € 5.03B | € 4.96B | € 4.76B | € 4.88B | € 4.08B |
Total Debt | € 2.20B | € 2.07B | € 2.07B | € 2.09B | € 1.72B |
Net Debt | € 672.80M | € 617.70M | € 573.70M | € 227.10M | € 433.90M |
Total Liabilities | - | - | - | - | - |
Stockholders Equity | € 1.79B | € 1.81B | € 1.74B | € 1.66B | € 1.51B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |